Transcranial Pulse Stimulation is another innovative development from the field of shock wave medicine, which is also consistent with regard to its diverse mode of action. Research into the medical applications of Shock waves has been going on since the 1940s. This is because the high-energy sound waves, as shock waves are also known in everyday life, can influence the behavior of body cells in a variety of ways.
Depending on the intensity of their energy, they have been used in the high-energy range since the 1980s to break up kidney stones and are now standard medical practice in this field. They are also known to have a firm place in orthopedics and are also used, far less well known, in cardiology, urology, dermatology and other medical disciplines.
The fact that they have now also found their way into the treatment of neurodegenerative diseases is only logical and consistent, because: Our cells act and communicate both biochemically (this is where drugs come in) and electrically, i.e. one can support cells of the human (and of course animal) organism in an activating, regulating and regenerating way with sound impulses.
The fact that today we can treat people with Alzheimer’s dementia – and in the future certainly other neurological diseases – with Transcranial Pulse Stimulation is mainly due to a physician whose pioneering work and development of Transcranial Pulse Stimulation cannot be appreciated enough: Henning Lohse-Busch, MD, a specialist in physical and rehabilitative medicine. It was he who recognized the potential of extracorporeal shock waves for neurological rehabilitation as early as the beginning of the 1990s and treated patients in a vegetative state, with incomplete paraplegia and spastic movement disorders under clinical conditions with fascinating results. Analogous to the further development of the technical modules for the use of low-energy shock waves for therapy on or in the brain, Alzheimer’s and Parkinson’s patients were added from 2012.
Multi-center clinical studies under the direction of Dr. med. Lohse-Busch and Prof. Dr. med. Roland Beisteiner, Head of the Faculty of Neurology at the Medical University of Vienna, which were realized starting in 2014, finally led to the CE approval of transcranial pulse stimulation in August 2018.
However, two more years of preparation time passed before the first clinics and practices, including Prof. Dr. med. Musa Citak as one of the first users, began to work with Transcranial Pulse Stimulation on an outpatient basis. In the meantime, however, Transcranial Pulse Stimulation is expanding rapidly, and rightly so, thanks to its good results, and Prof. Dr. med. Musa Citak may be counted among the leading users with the most extensive expertise in practical application.
Science and research are working intensively and extensively on studies and investigations of transcranial pulse stimulation – not only in relation to Alzheimer’s and dementia, but also to many other neurodegenerative diseases. Clinical papers are now published almost monthly, confirming the evidence of TPS more and more clearly. On the first German-language information portal on neurostimulation “Alzheimer Science” you will find from now on always up-to-date all scientific news on TPS and related topics: